{"id":"https://openalex.org/W2008530333","doi":"https://doi.org/10.4161/mabs.20652","title":"Pharmacokinetics of engineered human monomeric and dimeric CH2 domains","display_name":"Pharmacokinetics of engineered human monomeric and dimeric CH2 domains","publication_year":2012,"publication_date":"2012-06-28","ids":{"openalex":"https://openalex.org/W2008530333","doi":"https://doi.org/10.4161/mabs.20652","mag":"2008530333","pmid":"https://pubmed.ncbi.nlm.nih.gov/22699277","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3499341"},"language":"en","primary_location":{"id":"doi:10.4161/mabs.20652","doi":"https://doi.org/10.4161/mabs.20652","is_oa":true,"landing_page_url":"https://doi.org/10.4161/mabs.20652","pdf_url":null,"source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.4161/mabs.20652","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110435388","display_name":"Kurt R. Gehlsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131740","display_name":"Research Corporation Technologies (United States)","ror":"https://ror.org/03cac6636","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131740"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kurt R. Gehlsen","raw_affiliation_strings":["Research Corporation Technologies, Inc., Tucson, AZ USA. kgehlsen@rctech.com","Research Corporation Technologies, Inc","Tucson, AZ USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Corporation Technologies, Inc., Tucson, AZ USA. kgehlsen@rctech.com","institution_ids":["https://openalex.org/I4210131740"]},{"raw_affiliation_string":"Research Corporation Technologies, Inc","institution_ids":["https://openalex.org/I4210131740"]},{"raw_affiliation_string":"Tucson, AZ USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111782319","display_name":"Rui Gong","orcid":"https://orcid.org/0000-0001-9222-5642","observed_orcids":["https://orcid.org/0000-0001-9222-5642"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rui Gong","raw_affiliation_strings":["Protein Interactions Group; Frederick National Laboratory for Cancer Research; NIH; Frederick, MD USA","Frederick National Laboratory for Cancer Research","Frederick, MD USA","Protein Interactions Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Protein Interactions Group; Frederick National Laboratory for Cancer Research; NIH; Frederick, MD USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649"]},{"raw_affiliation_string":"Frederick National Laboratory for Cancer Research","institution_ids":["https://openalex.org/I4210130649"]},{"raw_affiliation_string":"Frederick, MD USA","institution_ids":[]},{"raw_affiliation_string":"Protein Interactions Group","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051462852","display_name":"Dave Bramhill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131740","display_name":"Research Corporation Technologies (United States)","ror":"https://ror.org/03cac6636","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131740"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dave Bramhill","raw_affiliation_strings":["Research Corporation Technologies, Inc.; Tucson, AZ USA","Research Corporation Technologies, Inc","Tucson, AZ USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Corporation Technologies, Inc.; Tucson, AZ USA","institution_ids":["https://openalex.org/I4210131740"]},{"raw_affiliation_string":"Research Corporation Technologies, Inc","institution_ids":["https://openalex.org/I4210131740"]},{"raw_affiliation_string":"Tucson, AZ USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086620854","display_name":"David A. Wiersma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131740","display_name":"Research Corporation Technologies (United States)","ror":"https://ror.org/03cac6636","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131740"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A. Wiersma","raw_affiliation_strings":["Research Corporation Technologies, Inc.; Tucson, AZ USA","Research Corporation Technologies, Inc","Tucson, AZ USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Corporation Technologies, Inc.; Tucson, AZ USA","institution_ids":["https://openalex.org/I4210131740"]},{"raw_affiliation_string":"Research Corporation Technologies, Inc","institution_ids":["https://openalex.org/I4210131740"]},{"raw_affiliation_string":"Tucson, AZ USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046844870","display_name":"Shaun A. Kirkpatrick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131740","display_name":"Research Corporation Technologies (United States)","ror":"https://ror.org/03cac6636","country_code":"US","type":"company","lineage":["https://openalex.org/I4210131740"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shaun A. Kirkpatrick","raw_affiliation_strings":["Research Corporation Technologies, Inc.; Tucson, AZ USA","Research Corporation Technologies, Inc","Tucson, AZ USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Corporation Technologies, Inc.; Tucson, AZ USA","institution_ids":["https://openalex.org/I4210131740"]},{"raw_affiliation_string":"Research Corporation Technologies, Inc","institution_ids":["https://openalex.org/I4210131740"]},{"raw_affiliation_string":"Tucson, AZ USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102836357","display_name":"Yangping Wang","orcid":"https://orcid.org/0000-0002-6226-0460","observed_orcids":["https://orcid.org/0000-0002-6226-0460"]},"institutions":[{"id":"https://openalex.org/I114662689","display_name":"Leidos (United States)","ror":"https://ror.org/012cvds63","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689"]},{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I880747138","display_name":"Science Applications International Corporation (United States)","ror":"https://ror.org/00zv91802","country_code":"US","type":"company","lineage":["https://openalex.org/I880747138"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yangping Wang","raw_affiliation_strings":["Protein Interactions Group; Frederick National Laboratory for Cancer Research; NIH; Frederick, MD USA; Basic Research Program; Science Applications International Corporation-Frederick, Inc.; NCI-Frederick; Frederick, MD USA","Basic Research Program","Frederick National Laboratory for Cancer Research","Frederick, MD USA","NCI-Frederick","Protein Interactions Group","Science Applications International Corporation-Frederick, Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Protein Interactions Group; Frederick National Laboratory for Cancer Research; NIH; Frederick, MD USA; Basic Research Program; Science Applications International Corporation-Frederick, Inc.; NCI-Frederick; Frederick, MD USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I880747138"]},{"raw_affiliation_string":"Basic Research Program","institution_ids":[]},{"raw_affiliation_string":"Frederick National Laboratory for Cancer Research","institution_ids":["https://openalex.org/I4210130649"]},{"raw_affiliation_string":"Frederick, MD USA","institution_ids":[]},{"raw_affiliation_string":"NCI-Frederick","institution_ids":["https://openalex.org/I4210130649"]},{"raw_affiliation_string":"Protein Interactions Group","institution_ids":[]},{"raw_affiliation_string":"Science Applications International Corporation-Frederick, Inc","institution_ids":["https://openalex.org/I114662689","https://openalex.org/I880747138"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112690536","display_name":"Yang Feng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yang Feng","raw_affiliation_strings":["Protein Interactions Group; Frederick National Laboratory for Cancer Research; NIH; Frederick, MD USA","Frederick National Laboratory for Cancer Research","Frederick, MD USA","Protein Interactions Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Protein Interactions Group; Frederick National Laboratory for Cancer Research; NIH; Frederick, MD USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649"]},{"raw_affiliation_string":"Frederick National Laboratory for Cancer Research","institution_ids":["https://openalex.org/I4210130649"]},{"raw_affiliation_string":"Frederick, MD USA","institution_ids":[]},{"raw_affiliation_string":"Protein Interactions Group","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089862290","display_name":"Dimiter Stanchev Dimitrov","orcid":"https://orcid.org/0000-0002-2258-1024","observed_orcids":["https://orcid.org/0000-0002-2258-1024"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dimiter S. Dimitrov","raw_affiliation_strings":["Protein Interactions Group; Frederick National Laboratory for Cancer Research; NIH; Frederick, MD USA","Frederick National Laboratory for Cancer Research","Frederick, MD USA","Protein Interactions Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Protein Interactions Group; Frederick National Laboratory for Cancer Research; NIH; Frederick, MD USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649"]},{"raw_affiliation_string":"Frederick National Laboratory for Cancer Research","institution_ids":["https://openalex.org/I4210130649"]},{"raw_affiliation_string":"Frederick, MD USA","institution_ids":[]},{"raw_affiliation_string":"Protein Interactions Group","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5110435388"],"corresponding_institution_ids":["https://openalex.org/I4210131740"],"apc_list":{"value":2915,"currency":"GBP","value_usd":3575},"apc_paid":{"value":2915,"currency":"GBP","value_usd":3575},"fwci":3.6208,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.92043701,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"4","issue":"4","first_page":"466","last_page":"474"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ch2-domain","display_name":"CH2 domain","score":0.8569999933242798},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7540000081062317},{"id":"https://openalex.org/keywords/fcrn-binding","display_name":"FcRn binding","score":0.8450000286102295},{"id":"https://openalex.org/keywords/circulating-half-life","display_name":"serum half-life","score":0.7509999871253967},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.7390000224113464},{"id":"https://openalex.org/keywords/cynomolgus-macaques","display_name":"cynomolgus macaques","score":0.9929999709129333},{"id":"https://openalex.org/keywords/igg1","display_name":"IgG1","score":0.5210000276565552},{"id":"https://openalex.org/keywords/antibody-fragments","display_name":"antibody fragments","score":0.5519999861717224},{"id":"https://openalex.org/keywords/targeted-drugs","display_name":"targeted therapeutics","score":0.621999979019165}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7568615674972534},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.725555956363678},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.686565637588501},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5828597545623779},{"id":"https://openalex.org/C2780649865","wikidata":"https://www.wikidata.org/wiki/Q21101413","display_name":"Neonatal Fc receptor","level":4,"score":0.48902711272239685},{"id":"https://openalex.org/C147816474","wikidata":"https://www.wikidata.org/wiki/Q169525","display_name":"Protein engineering","level":3,"score":0.4162508249282837},{"id":"https://openalex.org/C2780898057","wikidata":"https://www.wikidata.org/wiki/Q79448","display_name":"Immunoglobulin G","level":3,"score":0.364964097738266},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.35883980989456177},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.31981849670410156},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3149636387825012},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23575538396835327},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.21645310521125793},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.1477607786655426}],"mesh":[{"descriptor_ui":"D000595","descriptor_name":"Amino Acid Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D004591","descriptor_name":"Electrophoresis, Polyacrylamide Gel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D008252","descriptor_name":"Macaca fascicularis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008969","descriptor_name":"Molecular Sequence Data","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015202","descriptor_name":"Protein Engineering","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017434","descriptor_name":"Protein Structure, Tertiary","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055503","descriptor_name":"Protein Multimerization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.4161/mabs.20652","doi":"https://doi.org/10.4161/mabs.20652","is_oa":true,"landing_page_url":"https://doi.org/10.4161/mabs.20652","pdf_url":null,"source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2501538","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3499341","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3499341","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3499341","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MAbs","raw_type":"Text"},{"id":"pmid:22699277","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22699277","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.4161/mabs.20652","doi":"https://doi.org/10.4161/mabs.20652","is_oa":true,"landing_page_url":"https://doi.org/10.4161/mabs.20652","pdf_url":null,"source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8999999761581421,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1519854173","https://openalex.org/W1686249017","https://openalex.org/W1906279522","https://openalex.org/W1965067289","https://openalex.org/W1970875728","https://openalex.org/W1972018125","https://openalex.org/W1981947239","https://openalex.org/W1993059249","https://openalex.org/W1993575340","https://openalex.org/W1996538960","https://openalex.org/W2008925833","https://openalex.org/W2022228265","https://openalex.org/W2035118667","https://openalex.org/W2052505196","https://openalex.org/W2057520802","https://openalex.org/W2059976588","https://openalex.org/W2067258739","https://openalex.org/W2071843728","https://openalex.org/W2073047768","https://openalex.org/W2078317394","https://openalex.org/W2092900379","https://openalex.org/W2103719918","https://openalex.org/W2117131474","https://openalex.org/W2118167053","https://openalex.org/W2119562248","https://openalex.org/W2124140010","https://openalex.org/W2126703870","https://openalex.org/W2126977955","https://openalex.org/W2136782733","https://openalex.org/W2138906847","https://openalex.org/W2163478579","https://openalex.org/W2260710486"],"related_works":["https://openalex.org/W1992612195","https://openalex.org/W7096572334","https://openalex.org/W4409561895","https://openalex.org/W1526699428","https://openalex.org/W2060974842","https://openalex.org/W1992993067","https://openalex.org/W1944996883","https://openalex.org/W2138906847","https://openalex.org/W2079064937","https://openalex.org/W4308026498"],"abstract_inverted_index":{"Therapeutic":[0],"monoclonal":[1],"antibodies":[2],"have":[3,59,216],"several":[4],"advantages":[5],"over":[6],"small":[7,11,67],"molecule":[8],"drugs":[9],"and":[10,13,35,44,56,103,126,142,157,168,171,178,186,200,205],"proteins":[12],"peptides,":[14],"including":[15],"a":[16,72,89,111,122,143,223],"long":[17,21,113,218],"serum":[18,22,74,114,219],"half-life.":[19,115],"The":[20,81,160],"half-life":[23,75,162],"of":[24,47,76,86,91,121,128,137,163,173,197,229],"IgG":[25],"is":[26,96],"due,":[27],"in":[28,51,149,181,203],"part,":[29],"to":[30,38,65,98],"its":[31,36,129],"molecular":[32],"weight":[33],"(150kDa)":[34],"ability":[37],"bind":[39],"FcRn.":[40],"Both":[41],"the":[42,92,106,119,135],"CH2":[43,83],"CH3":[45],"domains":[46],"Fc":[48],"are":[49],"involved":[50],"FcRn":[52,93,154],"binding.":[53],"Antibody":[54],"fragments":[55],"antibody-like":[57,108],"scaffolds":[58],"improved":[60],"penetration":[61],"into":[62],"tissues":[63],"due":[64],"their":[66],"size,":[68],"yet":[69],"suffer":[70],"from":[71],"short":[73,144],"less":[77],"than":[78,195],"one":[79],"hour.":[80],"human":[82,153],"domain":[84],"(CH2D)":[85],"IgG1":[87],"retains":[88],"portion":[90],"binding":[94],"site,":[95],"amenable":[97],"modification":[99],"for":[100,227],"target":[101],"binding,":[102],"may":[104],"represent":[105],"smallest":[107],"scaffold":[109,225],"retaining":[110],"relatively":[112,217],"Here":[116],"we":[117],"describe":[118],"generation":[120],"dimeric":[123],"CH2D":[124,140,146],"(dCH2D)":[125],"determination":[127],"pharmacokinetics":[130],"(PK),":[131],"as":[132,134],"well":[133],"PK":[136],"wild-type":[138],"monomeric":[139],"(mCH2D)":[141],"stabilized":[145],"variant":[147],"(ssCH2D)":[148],"normal":[150],"B6":[151,182,204],"mice,":[152,183,207],"transgenic":[155],"mice":[156,185],"cynomolgus":[158,187],"macaques.":[159],"elimination":[161],"dCH2D":[164],"was":[165,175],"9.9,":[166],"10.4":[167],"11.2":[169],"hours,":[170,180],"that":[172,196,212],"ssCH2D":[174],"13.1,":[176],"9.9":[177],"11.4":[179],"hFcRn":[184,206],"macaques,":[188],"respectively.":[189,208],"These":[190,209],"half-lives":[191],"were":[192],"slightly":[193],"longer":[194],"mCH2D":[198],"(6.9":[199],"8.8":[201],"hours)":[202],"data":[210],"demonstrate":[211],"engineered":[213],"CH2D-based":[214],"variants":[215],"half-lives,":[220],"making":[221],"them":[222],"unique":[224],"suitable":[226],"development":[228],"targeted":[230],"therapeutics.":[231]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}